Jyothy Labs Limited has scheduled a one-on-one investor meeting with ICICI Securities for September 3, 2026. The engagement is part of the company's routine investor relations activities.

Meeting Details

The company disclosed the schedule in a filing to stock exchanges, citing Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Representatives of Jyothy Labs will attend the session. The firm explicitly stated that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared during the interaction.

The schedule remains subject to change due to exigencies on the part of the investor or the company. Shreyas Trivedi, Head – Legal & Company Secretary, signed the intimation dated September 1, 2026. Investors can access the latest presentation on the company's website.

Jyothy Laboratories received an excise duty order and penalty of ₹20.35 crore from the Commissionerate of Central Goods and Services Tax on August 24, 2026. The demand pertains to the period between April 2016 and June 2017.

The order was issued under Section 11A(10) of the Central Excise Act, 1944, read with Section 174(2) of the Central Goods and Services Tax Act, 2017. It stems from a difference in interpretation regarding the Harmonized System of Nomenclature (HSN) classification of a manufactured product and the resulting excise duty liability.

Demand Breakdown

The total liability includes principal duty, penalty, redemption fine, and applicable interest. The specific components of the demand are detailed below:

Legal Context and Appeal

Jyothy Labs noted that it had previously received a favorable order at another location concerning the same classification dispute. That earlier decision was accepted by the Excise Authorities and was not challenged before higher authorities.

The company is currently in the process of filing an appeal before the appellate authority against this latest order.

Financial Impact Assessment

Management stated that the company does not foresee any material impact on its financials, operations, or other activities consequent to the said order. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.